Literature DB >> 27335309

Long-term efficacy follow-up on two cryolipolysis case studies: 6 and 9 years post-treatment.

Eric F Bernstein1.   

Abstract

Cryolipolysis is a noninvasive esthetic procedure that utilizes controlled cooling to reduce subcutaneous fat. Clinical studies have established its safety, efficacy, and tolerability for fat reduction in a variety of areas including the abdomen, flanks, thighs, submental area, arms, back, and chest. Because of obvious esthetic concerns, long-term unilateral studies leaving an untreated flank, thigh, or arm are not performed, but serve as ideal controls for weight gain or loss or re-distribution of fat for other reasons. This article follows two patients previously documented in a case report to demonstrate their ongoing treatment efficacy at 6 and 9 years after treatment. Clinical photographs of the treated flanks and untreated contralateral controls demonstrate long-term durability in these two subjects.
© 2016 The Author. Journal of Cosmetic Dermatology Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  cryolipolysis; durability; long-term efficacy; longitudinal study; noninvasive body contouring; nonsurgical fat reduction

Mesh:

Year:  2016        PMID: 27335309     DOI: 10.1111/jocd.12238

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  2 in total

1.  Global Expert Opinion on Cryolipolysis Treatment Recommendations and Considerations: A Modified Delphi Study.

Authors:  Jens Altmann; A Jay Burns; Suzanne L Kilmer; Christopher Lee; Tingsong Lim; Andrei Metelitsa; W Grant Stevens; Amy Taub; Kathleen Welsh; Farid Kazem
Journal:  Aesthet Surg J Open Forum       Date:  2022-02-01

2.  High Participant Satisfaction Achieved Using Cryolipolysis for Fat Reduction of the Abdomen and Flanks.

Authors:  Terence Tan; Broughton Snell; Martin Braun; Sach Mohan; Esther Jo; Vaishali Patel; Suzanne Zheng; Stephanie Manson Brown; Matthew Hickling
Journal:  Aesthet Surg J       Date:  2022-06-20       Impact factor: 4.485

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.